The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase
due to the diabetes epidemic and its early and widespread appearance. CAN has a definite …

The incidence and prevalence of hypertension is increasing worldwide, with approximately
1.13 billion of people currently affected by the disease, often in association with other …

Caloric restriction that promotes weight loss is an effective strategy for treating non-alcoholic
fatty liver disease and improving insulin sensitivity in people with type 2 diabetes. Despite its …

Body fat mass increases when energy intake exceeds energy expenditure. In the long term,
a positive energy balance will result in obesity. The worldwide prevalence of obesity has …

Metabolic syndrome (Mets) is a clinical condition characterized by a cluster of major risk
factors for cardiovascular disease (CVD) and type 2 diabetes: proatherogenic dyslipidemia …

The central autonomic nervous system (ANS) is essential for maintaining cardiovascular and
respiratory homeostasis in the newborn and has a critical role in supporting higher cortical …

The role of the autonomic nervous system in obesity and insulin-resistant conditions has
been largely explored. However, the exact mechanisms involved in this relation have not …

Cardiac autonomic neuropathy (CAN) is a major complication of type 1 and type 2 diabetes
mellitus (T1DM and T2DM). The increased morbidity, cardiovascular and all-cause mortality …

Obesity-associated hypertension is a serious public health concern. Sympathetic nervous
system (SNS) overactivity, especially in the kidneys, is an important mechanism linking …

Abstract Purpose of Review Hypertension is related to impaired metabolic homeostasis and
can be regarded as a metabolic disorder. This review presents possible mechanisms by …